| Hypoxia-inducible factor signaling in pulmonary hypertension SS Pullamsetti, A Mamazhakypov, N Weissmann, W Seeger, R Savai The Journal of clinical investigation 130 (11), 5638-5651, 2020 | 137 | 2020 |
| Pulmonary hypertension in acute and chronic high altitude maladaptation disorders A Sydykov, A Mamazhakypov, A Maripov, D Kosanovic, N Weissmann, ... International journal of environmental research and public health 18 (4), 1692, 2021 | 76 | 2021 |
| Inflammatory mediators drive adverse right ventricular remodeling and dysfunction and serve as potential biomarkers A Sydykov, A Mamazhakypov, A Petrovic, D Kosanovic, AS Sarybaev, ... Frontiers in Physiology 9, 609, 2018 | 56 | 2018 |
| Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle H Luitel, A Sydykov, Y Schymura, A Mamazhakypov, W Janssen, ... Physiological Reports 5 (6), e13146, 2017 | 51 | 2017 |
| The role of chemokines and chemokine receptors in pulmonary arterial hypertension A Mamazhakypov, G Viswanathan, A Lawrie, RT Schermuly, S Rajagopal British Journal of Pharmacology 178 (1), 72-89, 2021 | 47 | 2021 |
| Right ventricular remodeling and dysfunction in obstructive sleep apnea: a systematic review of the literature and meta‐analysis A Maripov, A Mamazhakypov, M Sartmyrzaeva, A Akunov, K Muratali uulu, ... Canadian respiratory journal 2017 (1), 1587865, 2017 | 44 | 2017 |
| Loss of LRP1 promotes acquisition of contractile-myofibroblast phenotype and release of active TGF-β1 from ECM stores J Schnieder, A Mamazhakypov, A Birnhuber, J Wilhelm, G Kwapiszewska, ... Matrix Biology 88, 69-88, 2020 | 35 | 2020 |
| Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice K Pradhan, A Sydykov, X Tian, A Mamazhakypov, B Neupane, H Luitel, ... International Journal of Cardiology 216, 85-91, 2016 | 32 | 2016 |
| Lipids: Two sides of the same coin in lung fibrosis A Mamazhakypov, RT Schermuly, L Schaefer, M Wygrecka Cellular signalling, 2019 | 22 | 2019 |
| The role of G protein-coupled receptors in the right ventricle in pulmonary hypertension G Viswanathan, A Mamazhakypov, RT Schermuly, S Rajagopal Frontiers in Cardiovascular Medicine 5, 179, 2018 | 19 | 2018 |
| Pirfenidone inhibits motility of NSCLC cells by interfering with the urokinase system M Krämer, P Markart, F Drakopanagiotakis, A Mamazhakypov, L Schaefer, ... Cellular signalling 65, 109432, 2020 | 16 | 2020 |
| High altitude pulmonary hypertension with severe right ventricular dysfunction SA Maripov, A., Mamazhakypov, A., Karagulova, G., Sydykov, A. International journal of cardiology 168, e89-e90, 2013 | 16 | 2013 |
| Clinical and molecular implications of osteopontin in heart failure A Mamazhakypov, M Sartmyrzaeva, AS Sarybaev, R Schermuly, ... Current Issues in Molecular Biology 44 (8), 3573-3597, 2022 | 12 | 2022 |
| Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats A Mamazhakypov, A Weiß, S Zukunft, A Sydykov, B Kojonazarov, ... Pulmonary circulation 10 (4), 2045894020947283, 2020 | 12 | 2020 |
| Circulating apoptotic signals during acute and chronic exposure to high altitude in Kyrgyz population D Kosanovic, SM Platzek, A Petrovic, A Sydykov, A Maripov, ... Frontiers in Physiology 10, 54, 2019 | 12 | 2019 |
| Novel therapeutic targets for the treatment of right ventricular remodeling: insights from the pulmonary artery banding model A Mamazhakypov, N Sommer, B Assmus, K Tello, RT Schermuly, ... International Journal of Environmental Research and Public Health 18 (16), 8297, 2021 | 10 | 2021 |
| Mineralocorticoid receptors in pulmonary hypertension and right heart failure: from molecular biology to therapeutic targeting A Mamazhakypov, L Hein, A Lother Pharmacology & Therapeutics 231, 107987, 2022 | 9 | 2022 |
| Genetic deficiency and pharmacological stabilization of mast cells ameliorate pressure overload-induced maladaptive right ventricular remodeling in mice A Sydykov, H Luitel, A Mamazhakypov, M Wygrecka, K Pradhan, O Pak, ... International Journal of Molecular Sciences 21 (23), 9099, 2020 | 8 | 2020 |
| Cancer and pulmonary hypertension: Learning lessons and real-life interplay SS Pullamsetti, S Nayakanti, P Chelladurai, A Mamazhakypov, ... Global Cardiology Science & Practice 2020 (1), 2020 | 8 | 2020 |
| Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties H Luitel, T Novoyatleva, A Sydykov, A Petrovic, A Mamazhakypov, ... Medicina 56 (3), 131, 2020 | 8 | 2020 |
Akylbek SydykovM.D., PhD在 innere.med.uni-giessen.de 的电子邮件经过验证
